Posttransplant cyclophosphamide-based graft-vs-host disease (GVHD) prophylaxis enabled high 1-year overall survival in patients receiving peripheral blood stem cell (PBSC) transplants from human ...

"We're trying to move away a little bit from the notion that seven out of eight or six out of eight is better than five out ...

Less emphasis on full HLA matching means clinicians can find an appropriate donor for any patient, says Antonio Jimenez ...

Achieving donor chimerism or GVHD after infusion boosted survival only in relapse cases without prior GVHD, revealing a key ...